Gaining the Greatest Insight from IND-Enabling Studies with CertisAI™ & Advanced Cancer Models
Time: 3:30 pm
day: Conference Day One
Details:
- Accelerating drug discovery with in silico models that save time and money — predict therapeutic efficacy, disease indications, and model selection, identify biomarker signatures and more
- Ensuring clinical accuracy with advanced orthotopic PDX models that reliably mirror the behavior of cancer in their human counterparts
- Reducing variability between in vitro and in vivo studies by employing matched pairs of PDX models and 3D cell cultures derived from the same PDX models
